FINWIRES · TerminalLIVE
FINWIRES

Update: Rezolute Shares Rise After Participants Meet Responder Criterion in Phase 3 Tumor Hyperinsulinism Trial

By

(Updates with the latest stock move in the headline and in the first paragraph.)

Rezolute (RZLT) shares rose about 16% in Tuesday afternoon trading after the company said that six of eight participants enrolled in a phase 3 trial of ersodetug in uncontrolled hypoglycemia caused by tumor hyperinsulinism have already met the responder criterion for the study's primary endpoint.

The primary endpoint of the study, which aims to enroll 16 patients with insulinoma or non-islet cell tumors, is the number of participants achieving at least a 50% reduction from baseline in intravenous glucose requirements within the 8-week pivotal treatment phase, the company said.

Rezolute said ersodetug has been well-tolerated in the pivotal and extension phases of the study, with no drug-related adverse events or other safety findings reported to date.

Topline results for the fully enrolled open-label phase 3 study are expected in H2, Rezolute said.

Price: $4.18, Change: $+0.57, Percent Change: +15.65%

Related Articles

Wire

Update: Northern Star Resources Should Launch Strategic Review, Explore Sale, Activist Investor Elliott Says; Shares Up 9%

(Updates to add stock movement in the headline and last paragraph)Northern Star Resources (ASX:NST) should conduct a strategic review that includes a potential sale, alongside a search for a new CEO, to identify opportunities for operational improvements, shareholder Elliott Investment Management said Monday.Elliott disclosed a stake of over AU$1 billion in Northern Star Resources, saying it wants to work with the company to maximize shareholder value."Northern Star's recent pattern of operational missteps, cost overruns and inconsistent strategic direction demands urgent action," Elliott said, adding that the company has underperformed its potential despite holding world-class gold assets.The activist investor also urged the company to supplement its board with "fresh perspectives" to help guide the review and subsequent steps.Elliott further alleged that Northern Star has "deeply inadequate disclosures compared to global senior peers." The company is likely to draw "significant strategic interest" if it explores a sale, Elliott said.Northern Star Resources did not immediately reply to a request for comment from.The company's shares rose around 9% in recent Tuesday trade.

ASX:NST
Wire

Xometry Plans Offering of Class A Shares

Xometry (XMTR) said Monday it has started an underwritten public offering of $225 million of its Class A shares, subject to market conditions.Underwriters will be given a 30-day option to buy up to an additional $33.75 million of shares, the company said.Net proceeds from the planned offering are for working capital and general corporate purposes, Xometry said.Xometry shares were down past 9% in after-hours activity.

$XMTR
Wire

LXP Industrial Trust Revises 2026 Adjusted FFO Guidance

LXP Industrial Trust (LXP) said late Monday it now expects 2026 adjusted funds from operations per diluted share of $3.30 to $3.40 from $3.22 to $3.37 earlier.Analysts polled by FactSet expected $3.28.In May, the company acquired a 37-acre infill industrial redevelopment site in the South Airport submarket of Phoenix for $103 million, according to a statement.The site produces annual rent of $16.1 million, with 2% annual rent hikes, the company said.

$LXP